Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 120 participants.
Also called NCT03696940
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 120 participants
- Sponsor
- Laboratorios Grossman, S.A.
- Registry
-
NCT03696940
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Mexico
- Registry status
- Unknown status
Technical summary
Registry record NCT03696940. Randomized; single masking; primary purpose treatment. Start 2018-05-28 (actual); primary completion 2019-03-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
- Condition
- Dyslipidemias
- Condition
- Cardiovascular Risk Factor
- Intervention (Drug)
- L-Carnitine 500Mg Oral Tablet + Atorvastatin 10 mg
- Intervention (Drug)
- Atorvastatin 10mg
- Lead sponsor
- Laboratorios Grossman, S.A.
- Collaborator
- Instituto Nacional de Salud Publica, Mexico
Record details
- Record id
cardio:ct-nct03696940- Content hash
9f92022f26267139525ede7716132152b310332bba1b1b6ba97b7505354c3b16